SCCM

Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exa

Retrieved on: 
Wednesday, March 6, 2024

The award is in recognition of the HYPERACT study – a new multi-center, randomized controlled trial which offers high velocity therapy as an additional, more comfortable, option for clinicians treating acute exacerbations of moderate-severe COPD.

Key Points: 
  • The award is in recognition of the HYPERACT study – a new multi-center, randomized controlled trial which offers high velocity therapy as an additional, more comfortable, option for clinicians treating acute exacerbations of moderate-severe COPD.
  • Acute exacerbations of COPD contribute to over 600K emergency room (ER) visits and 140K deaths annually in the US alone.
  • "This study concludes that high velocity therapy provides similar clinical results and statistically superior patient reported comfort compared to mask-based therapies."
  • (3)
    Dr. Yamane was presented with the award at the 2024 Critical Care Congress on January 23rd, 2024, in Phoenix, AZ.

Accurate Identification of Sepsis using SeptiCyte® RAPID and Comparison with other Biomarkers Presented at Society of Critical Care Medicine (SCCM) Critical Care Congress 2024

Retrieved on: 
Monday, January 22, 2024

SEATTLE and BRISBANE, Australia, Jan. 22, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced  that data validating the use of SeptiCyte® RAPID in differentiating sepsis from systemic inflammatory response syndrome (SIRS) was selected for presentation on Sunday, January 21, during the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress in Phoenix, Arizona, January 21 to 23, 2024.

Key Points: 
  • Immunexpress Chief Medical Officer Dr. Roy Davis presented the poster entitled, "Accurate Sepsis Identification Using SeptiCyte® RAPID & Other Biomarkers of Systemic Inflammation" in a Research Snapshot theatre and fielded questions afterward in a Q&A discussion.
  • "The data demonstrate that no combination of biomarkers outperformed SeptiScore alone, or models including SeptiScore, at identifying sepsis," said Dr. Roy Davis, MD, PhD, MHA, Chief Medical Officer of Immunexpress.
  • "This is clinically meaningful as it demonstrates that SeptiCyte RAPID can be used to help diagnose sepsis more accurately than current sepsis diagnostic tools or clinical variables.
  • SeptiCyte RAPID isn't intended to be used as a standalone test, but in this study adding other biomarkers to SeptiScore didn't appreciably increase the diagnostic certainty of differentiating sepsis from SIRS."

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

Retrieved on: 
Monday, January 22, 2024

DUBLIN, Jan. 22, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of findings from a post hoc analysis of the Phase 3 CONFIRM clinical trial. In this analysis, treatment with TERLIVAZ® (terlipressin) for injection was associated with improvements in verified hepatorenal syndrome (HRS) reversal and HRS reversal vs. placebo in adult cirrhosis patients with alcoholic hepatitis (AH) and HRS with rapid reduction in kidney function.1,2 The results will be shared in an oral presentation at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress, taking place January 21-23, 2024, in Phoenix, AZ.

Key Points: 
  • Patients with volume overload or with acute-on-chronic liver failure (ACLF) Grade 3 are at increased risk.
  • Monitor patients for hypoxia using continuous pulse oximetry during treatment and discontinue TERLIVAZ if SpO2 decreases below 90%.
  • Ineligibility for Liver Transplant: TERLIVAZ-related adverse reactions (respiratory failure, ischemia) may make a patient ineligible for liver transplantation, if listed.
  • For patients with high prioritization for liver transplantation (e.g., MELD ≥35), the benefits of TERLIVAZ may not outweigh its risks.

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress

Retrieved on: 
Tuesday, January 16, 2024

Oak Ridge, TN, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Society for Critical Care Medicine (SCCM) 2024 Critical Care Congress at the Phoenix Convention Center in Phoenix, AZ from January 21 through January 23, 2024.

Key Points: 
  • Oak Ridge, TN, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Society for Critical Care Medicine (SCCM) 2024 Critical Care Congress at the Phoenix Convention Center in Phoenix, AZ from January 21 through January 23, 2024.
  • Highlighting the significance of this meeting as the leading critical care conference globally and presenting a substantial opportunity for Daxor to extend its presence within this specialized field, Michael Feldschuh, Daxor’s CEO and President, said, “Our diagnostic has shown its value in guiding care to optimal volume in areas such as heart failure and critical care.
  • Furthermore, these interventions resulted in reduced patient hospital stays and fewer days spent on a ventilator."
  • The Company will be exhibiting at Booth #936.

Targus Introduces Key Enhancements to its Award-Winning MiraLogic Workspace Intelligence System Designed to Boost Enterprise Productivity, Reduce Costs, and Improve Sustainability Across an Enterprise

Retrieved on: 
Monday, January 8, 2024

LAS VEGAS, Jan. 7, 2024 /PRNewswire/ -- CES®, Booth #15945, LV Convention Center, Central Hall -- Targus®, the number one laptop bag brand in the US1 and a leader in laptop cases and mobile computing accessories, today introduced several innovative enhancements to its award-winning MiraLogic® Workspace Intelligence System. This unique workspace platform combines enterprise-grade hardware with proprietary software to enable enterprise teams to monitor and maintain their modular IT ecosystems from anywhere.

Key Points: 
  • This unique workspace platform combines enterprise-grade hardware with proprietary software to enable enterprise teams to monitor and maintain their modular IT ecosystems from anywhere.
  • MiraLogic allows enterprise decisionmakers to understand and optimize power consumption, maximize available office space, and help employees work more productively and flexibly from anywhere.
  • These are just some of the reasons why MiraLogic was named a CES 2024 Innovation Award Honoree .
  • "MiraLogic helps organizations solve these challenges by enabling them to reassess their working practices, aligning future decision-making around those priorities."

Targus' MiraLogic Workspace Intelligence System Named a CES 2024 Innovation Award Honoree in the Sustainability, Eco-Design & Smart Energy Category

Retrieved on: 
Wednesday, November 15, 2023

ANAHEIM, Calif., Nov. 15, 2023 /PRNewswire/ -- Targus®, the number one laptop bag brand in the US1 and a leader in laptop cases and mobile computing accessories, today announced that its MiraLogic® Workspace Intelligence System has been named a CES® 2024 Innovation Award Honoree in the Sustainability, Eco-Design & Smart Energy category. CES' elite panel of judges recognized MiraLogic as one of the most innovative products being introduced at CES 2024 which demonstrates key features and benefits that contribute to a more sustainable planet.

Key Points: 
  • CES' elite panel of judges recognized MiraLogic as one of the most innovative products being introduced at CES 2024 which demonstrates key features and benefits that contribute to a more sustainable planet.
  • This allows organizations to efficiently analyze, control, and manage their workspace assets anywhere (e.g., power consumption, workspace utilization, and real-time occupancy).
  • MiraLogic helps organizations solve these challenges by enabling them to reassess their working practices, aligning future decision-making around those priorities."
  • Additionally, this revolutionary workspace management system will be on display in the CES Innovation Awards Showcase and at CES Unveiled , CES' premier media preview event taking place at the Mandalay Bay Convention Center on the evening of January 7th.

New Guidance Issued on the Determination of Brain Death AAN, AAP, CNS and SCCM Develop Consensus Practice Guideline

Retrieved on: 
Thursday, October 12, 2023

MINNEAPOLIS, Oct. 11, 2023 /PRNewswire/ -- New guidance has been issued for clinicians on the determination of brain death, also known as death by neurologic criteria.

Key Points: 
  • MINNEAPOLIS, Oct. 11, 2023 /PRNewswire/ -- New guidance has been issued for clinicians on the determination of brain death, also known as death by neurologic criteria.
  • This guideline updates the 2010 AAN adult practice guidelines and the 2011 AAP/CNS/SCCM pediatric practice guidelines on the determination of brain death.
  • Because of a lack of high-quality evidence on the subject, the experts used an evidence-informed consensus process to develop the guideline.
  • The consensus practice guideline outlines the standardized procedure for trained clinicians to evaluate people for brain death.

Aiden Completes $4.5 Million Round of Seed Funding

Retrieved on: 
Wednesday, May 3, 2023

MCKINNEY, Texas, May 3, 2023 /PRNewswire/ -- Aiden Technologies, the provider of modern, intelligent software packaging and deployment for Microsoft Windows, has secured $4.5 million in its second round of seed funding. The co-lead investors in this round of funding are Right Side Capital Management and Blu Venture Investors. Right Side was also the largest investor in Aiden's initial round of funding in 2021, when it raised its initial $2.9 million seed funding.

Key Points: 
  • Aiden Enables Companies to Overcome Obstacles for Adopting Microsoft Modern Workplace; Dramatically Improves Cybersecurity Posture of Windows-Based Organizations
    MCKINNEY, Texas, May 3, 2023 /PRNewswire/ -- Aiden Technologies, the provider of modern, intelligent software packaging and deployment for Microsoft Windows , has secured $4.5 million in its second round of seed funding.
  • The co-lead investors in this round of funding are Right Side Capital Management and Blu Venture Investors .
  • Right Side was also the largest investor in Aiden's initial round of funding in 2021, when it raised its initial $2.9 million seed funding.
  • "Aiden has a dramatic impact on the cybersecurity posture of organizations that rely on Windows.

Virsec Automates Zero-Day Attack Prevention for Workloads; Proven to Stop Known and Unknown Attacks Before Exploitation

Retrieved on: 
Thursday, April 20, 2023

Virsec turns a previously hard-to-use protection approach into a usable solution for security teams of any maturity level.

Key Points: 
  • Virsec turns a previously hard-to-use protection approach into a usable solution for security teams of any maturity level.
  • Detection and response solutions (EDRs) are an established mechanism to secure server workloads, despite their known gaps in stopping attacks before exploitation.
  • The time it takes for EDR solutions to build behavioral and AI models to spot attacks far exceeds the time for an attack to take hold.
  • Virsec, by default, takes the exact opposite approach of EDRs and blocks and prevents any known or unknown threat in milliseconds—before the attack fully executes.

Worldwide Serverless Architecture Industry to 2027: Growing IoT Ecosystem Leading to the Emergence of Serverless Architecture Applications

Retrieved on: 
Friday, February 24, 2023

The term "Serverless Architecture" refers to a computer architecture that enables programmers to create and run programs without having to provide, set up, or manage infrastructure.

Key Points: 
  • The term "Serverless Architecture" refers to a computer architecture that enables programmers to create and run programs without having to provide, set up, or manage infrastructure.
  • This style of serverless computing, also known as "functions as a service," makes use of transient functions that form applications that are run inside of a serverless architecture.
  • Growing IoT ecosystem leading to the emergence of serverless architecture application:
    The shift of various industries into a data-driven framework as a result of rapid technical advancements and innovations has created enormous potential.
  • In this report, global serverless architecture market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: